Context Therapeutics Inc.
CNTX
$0.8595
-$0.0134-1.54%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 83.52M | 89.35M | 94.43M | 84.80M | 101.54M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.23M | 3.18M | 3.47M | 1.27M | 1.16M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 200.00K | 200.00K | -- | -- | -- |
Total Current Assets | 86.95M | 92.73M | 97.90M | 86.07M | 102.70M |
|
|||||
Total Current Assets | 86.95M | 92.73M | 97.90M | 86.07M | 102.70M |
Net Property, Plant & Equipment | 203.90K | 234.70K | 230.80K | 259.00K | 10.40K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 87.15M | 92.97M | 98.13M | 86.33M | 102.71M |
|
|||||
Total Accounts Payable | 2.40M | 1.00M | 1.45M | 1.03M | 611.50K |
Total Accrued Expenses | 2.01M | 710.40K | 2.33M | 1.11M | 981.80K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 115.00K | 111.10K | 107.30K | 104.20K | -- |
Total Finance Division Other Current Liabilities | 37.70K | 77.30K | 49.80K | 89.80K | 11.00K |
Total Other Current Liabilities | 37.70K | 77.30K | 49.80K | 89.80K | 11.00K |
Total Current Liabilities | 4.56M | 1.90M | 2.75M | 2.33M | 1.60M |
|
|||||
Total Current Liabilities | 4.56M | 1.90M | 2.75M | 2.33M | 1.60M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 52.30K | 82.60K | 112.10K | 140.20K | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.61M | 1.98M | 2.86M | 2.47M | 1.60M |
|
|||||
Common Stock & APIC | 190.73M | 190.34M | 190.05M | 175.29M | 175.08M |
Retained Earnings | -108.18M | -99.36M | -94.78M | -91.44M | -73.98M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 82.54M | 90.98M | 95.27M | 83.86M | 101.10M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 82.54M | 90.98M | 95.27M | 83.86M | 101.10M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 82.54M | 90.98M | 95.27M | 83.86M | 101.10M |
|